−1.63USD
−135.96 MUSD
73.88 M
About Atea Pharmaceuticals, Inc.
Sector
CEO
Jean-Pierre Sommadossi
Headquarters
Boston
Website
Employees (FY)
75
Founded
2012
ISIN
US04683R1068
FIGI
BBG00TZNCJ75
Atea Pharmaceuticals, Inc. is a clinical stage company, which focuses on discovering, developing, and commercializing antiviral therapeutics. Its product pipelines include Coronaviridae, Flaviviridae, and Paramyxovirdae. The company was founded by Jean-Pierre Sommadossi and David Chu in July 2012 and is headquartered in Boston, MA.
AVIR 7.4 R short move to prior high2nd biggested pre-market gainer provided a low risk short entry with target prior day high.
Avir breakout Atea has given a breakout after bottom formation, and now retesting the support. Long trade seems good. Sl: 25. With Good phase II interim result might have a good run
Disclaimer: The stock/index/currency discussed do not constitute Investment/trading advise and is merely an effort towards enhanci
Sunday Prep 8/08 - $AVIR I don’t usually put stocks that trade less than 2m shares/day on average on my watchlist but this chart is too sexy to pass up. I’ll be looking for a pullback to the annual pivot just below 30 and the monthly pivot at 29.41 as areas of Interest. The only real problem I have with this setup is that
AVIR - Long Setup Appears to have heavy options exercise in November but no selling yet. Break 24.53. Stop signal 21.43.First Target 29.77, 2nd Target Momentum.
US Stock In Play: $AVIR (Atea Pharmaceuticals Inc)$AVIR continue its surge it share price, with a overall cumulative gain of +38.31% since it was last highlighted this month. The continuation of all time high breakout have successfully negated two series of Bearish Shooting Star reversal candlestick pattern that was printed on 14th and 15th January
US Stock In Play: $AVIR (Atea Pharmaceuticals Inc)$AVIR capped off the week’s market session with a considerable gain of +15.03%. This morning’s continuation all time high breakout have successfully negated the Bearish Shooting Star reversal candlestick pattern that was printed on 4th January 2021. The week’s rally also sums up an impressive cumula
$AVIR is giving a GREAT IPO LONG opportunity todayIPO intraday trading strategy idea
Atea Pharmaceuticals is a biopharmaceutical company engaged in the discovery and development of next-generation therapeutics for severe human viral infections.
The share price is rising and gonna continue this trend today.
The demand for shares of the company st
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of AVIR is 3.74 USD — it has decreased by 0.53% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Atea Pharmaceuticals, Inc. stocks are traded under the ticker AVIR.
Atea Pharmaceuticals, Inc. is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Atea Pharmaceuticals, Inc. has a max estimate of 5.00 USD and a min estimate of 2.00 USD.
AVIR earnings for the last quarter are −0.40 USD whereas the estimation was −0.46 USD which accounts for 13.50% surprise. Estimated earnings for the next quarter are −0.43 USD. See more details about Atea Pharmaceuticals, Inc. earnings.
Atea Pharmaceuticals, Inc. revenue for the last quarter amounts to 192.18 M USD despite the estimated figure of 85.73 M USD. In the next quarter revenue is expected to reach 3.33 M USD.
Yes, you can track Atea Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, AVIR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Atea Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 16, 2024, the company has 75.00 employees. See our rating of the largest employees — is Atea Pharmaceuticals, Inc. on this list?